Article
An evaluation of ribonuclease protection assays for the detection of beta-cardiac myosin heavy chain gene mutations.
Circulation - 1 Jan 1994
MacRae C A, Watkins H C, Jarcho J A, Thierfelder L, McKenna W J, Seidman J G, Seidman C E
Abstract excerpt
BACKGROUND: Ribonuclease (RNase) protection has been used to identify beta-cardiac myosin heavy chain (MHC) gene mutations that cause familial hypertrophic cardiomyopathy (FHC). Since more than 10 different mutations within this gene have been demonstrated to cause FHC in unrelated individuals, the genetic diagnosis of this condition will involve screening the beta-MHC gene. The accuracy with which RNase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.